THE PROBLEM OF ADHERENCE TO THE TREATMENT IN MODERN MEDICINE: POSSIBILITIES OF SOLUTION, IMPACT ON THE EFFECTIVENESS OF THERAPY AND DISEASE OUTCOMES
https://doi.org/10.20996/1819-6446-2017-13-4-519-524
Abstract
The problem of adherence remains one of the currently important and at the same time the most difficult one to solve for modern medicine and society. Despite five decades of scientific research on this issue, numerous attempts to create reliable diagnostic tests, the search for methods to increase patient adherence to the medical recommendations, nevertheless, most of the questions on this topic remain unanswered. Adherence is a proven factor that greatly influences the effectiveness of treatment and the outcomes of the disease. The article discusses some reasons explaining the absence of significant breakthroughs in solving the problem of adherence: (1) unresolved issues with terminology, especially the lack of Russian-language terms, the absence of both a uniform definition of "adherence", which takes into account the variety of aspects included in it and a generally accepted classification of terms by the topic; (2) a lack of reliable diagnostic tests that are convenient for clinical practice, and the absence of a "gold standard" method for diagnosing adherence; (3) a lack of valid diagnostic tests to determine the adherence of physicians to the clinical recommendations and official medicine usage instructions as well as tests to assess the quality of therapy; (4) a large and growing number of identified factors that influence adherence, and usually not taken into account the mutual influence of these factors; (5) frequent inattention to fact that in the same patients there may be different adherence to different medicines, etc. Besides, the possible prospects for future researches are identified, in particular the need to assess adherence inseparably to the quality control of treatment, as well as the importance of a comprehensive impact on all or at least most of the factors and aspects of adherence identified to date.
About the Authors
Yu. V. Lukina
National Medical Research Center for Preventive Medicine
Russian Federation
Russian Federation
MD, PhD, Leading Researcher, Department of Preventive Pharmacotherapy,
Petroverigsky per. 10, Moscow, 101990
N. P. Kutishenko
National Medical Research Center for Preventive Medicine
Russian Federation
Russian Federation
MD, PhD, Head of Laboratory for Pharmacoepidemiological Studies, Department of Preventive Pharmacotherapy,
Petroverigsky per. 10, Moscow, 101990
S. Yu. Martsevich
National Medical Research Center for Preventive Medicine
Russian Federation
Russian Federation
MD, PhD, Professor, Head of Department of Preventive Pharmacotherapy,
Petroverigsky per. 10, Moscow, 101990
References
1. Adams F. The genuine works of Hippocrates. Melbourne, FL: Krieger Publishing; 1972.
2. Turner B.J., Hecht F.M. Improving on a coin toss to predict patient adherence to medications. Ann Intern Med. 2001;134(10):1004-6.
3. World Health Organization. Adherence to long-term therapies: evidence for action. WHO Library Cataloguing-in-Publication Data. Geneva: WHO; 2003.
4. Lukina Yu.V., Kutishenko N.P., Martsevich S.Yu. Treatment adherence: modern view on a well known issue. Kardiovaskulyarnaya Terapiya i Profilaktika. 2017;16(1):91-5. (In Russ.) [Лукина Ю.В., Кутишенко Н.П., Марцевич С.Ю. Приверженность лечению: современный взгляд на знакомую проблему. Кардиоваскулярная Терапия и Профилактика. 2017;16(1):91-5].
5. Schroeder K., Fahey T., Ebrahim S. How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med. 2004;164(7):722-32.
6. Ageev F.T., Smirnova M.D., Fofanova T.V. Increase adherence to therapy: "the matter of technology"? Serdechnaya Nedostatochnost'. 2011;12(4):66. (In Russ.) [Агеев Ф. Т., Смирнова М. Д., Фофанова Т. В.Повышение приверженности к терапии: «дело техники»? Сердечная Недостаточность. 2011; 12(4):66].
7. Morisky D.E., Ang A., Krousel-Wood M., Ward H.J. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-54.
8. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-97.
9. Jin J., Sklar G. E., Oh M.N.S, Li S.C. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269-86.
10. Brow M.T., Bussell J.K. Medication Adherence: WHO Cares? Mayo Clin Proc. 2011;86(4):304-14.
11. Semenova O.N., Naumova E.A., Schwartz Y.G. Adherence to long-term treatment of cardiovascular disease and non-compliance with medical recommendations: the opinion of patients and physicians by the results of focused interview. Rational Pharmacotherapy in Cardiology. 2014;10(1):55-61. (In Russ.) [Семенова О.Н., Наумова Е.А., Шварц Ю.Г. Приверженность длительному лечению сердечно-сосудистых заболеваний и невыполнение врачебных рекомендаций: мнение пациентов и врачей по результатам фокусированного интервью. Рациональная Фармакотерапия в Кардиологии. 2014;10(1):55-61].
12. Suvorova K.D. Aphorisms of great doctors.Hippocrates, Galen, Avicenna, Arnold of Villanova, Paracelsus. St. Petersburg: OlmaMediaGroup / Enlightenment; 2017. (In Russ.) [Суворова К.Д. Афоризмы великих врачей. Гиппократ, Гален, Авиценна, Арнольд из Виллановы,Парацельс. Санкт-Петербург: ОлмаМедиаГрупп/Просвещение; 2017.
13. Garner J.B. Problems of nonadherence in cardiology and proposals to improve outcomes. Am J Cardiol. 2010;105:1495-501.
14. Viana M., Laszczynska O., Mendes S., et al. Medication adherence to specific drug classes in chronic heart failure. J Manag Care Spec Pharm. 2014;20(10):1018-26.
15. de Vries S.T., Keers J.C., Visser R., et al. Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes. J Psychosom Res. 2014;76(2):134-8.
16. Кaplan N.M.,Victor R.G., Flynn J.T. Kaplan’s clinical hypertension. Eleventh edition. Philadelphia: Wolters Kluwer; 2015
17. Kleinsinger F. Working with the Noncompliant Patient. The Permanente Journal. 2010;14(1):54-60.
18. Roter D.L., Hall J.A., Merisca R., et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36(8):1138 -61.
19. Olshansky B. Placebo and nocebo in cardiovascular health: implications for healthcare, research, and the doctor-patient relationship. J Am Coll Cardiol. 2007;49(4):415-21.
20. Minakov E.V., Khokhlov R.A., Furmenko G.I., Akhmedzhanov N.M. Doctor inertness as a factor disturbing effective treatment of cardiovascular diseases. Rational Pharmacotherapy in Cardiology. 2009;5(2):39-48. (In Russ) [Минаков Э.В., Хохлов Р.А., Фурменко Г.И., Ахмеджанов Н.М. Kлиническая инертность как фактор, препятствующий эффективному лечению сердечно-сосудистых заболеваний. Рациональная Фармакотерапия в Кардиологии. 2009;5(2):39-48].
21. Boytsov S.A., Martsevich S.Yu., Ginzburg M.L. et al. Lyubertsy study on mortality rate in patients after cerebral stroke or transient ischemic attack (LIS-2). Design and medical treatment estimation. Rational Pharmacotherapy in Cardiology. 2013; 9(2):114-22. (In Russ.) [Бойцов С.А., Марцевич С.Ю., Гинзбург М.Л. и соавт. от имени рабочей группы исследования «ЛИС-2». Люберецкое исследование смертности больных, перенесших мозговой инсульт или транзиторную ишемическую атаку (ЛИС-2).Дизайн и оценка лекарственной терапии. Рациональная Фармакотерапия в Кардиологии. 2013;9(2):114-22].
22. Lukina Y.V., Gynzburg M.L., Smirnov V.P. et al. Treatment compliance in patients with acute coronary syndrome before hospitalization. Clinicist. 2012;2:41-9. (In Russ.) [Лукина Ю.В., Гинзбург М.Л., Смирнов В.П. и соавт. Приверженность к лечению, предшествующему госпитализации, у пациентов с острым коронарным синдромом. Клиницист. 2012; 2:41-9].
23. Suvorov A.Y., Martsevich S.Y., Kutishenko N.P. et al. The way of assessing the adherence to modern drug therapy clinical guidelines aimed at reducing the risk of recurrent stroke (according to the LIS-2 register). Rational Pharmacotherapy in Cardiology. 2015;11(1):45-52. (In Russ.) [Суворов А.Ю., Марцевич С.Ю., КутишенкоН.П. и соавт. от имени рабочей группыисследования «ЛИС-2». Способ оценки соответствия современным клиническим рекомендациям медикаментозной терапии, направленной на снижение риска повторного инсульта (по данным регистра ЛИС-2). Рациональная Фармакотерапия в Кардиологии. 2015; 11(1):45-52].
Review
For citations:
Lukina Yu.V., Kutishenko N.P., Martsevich S.Yu. THE PROBLEM OF ADHERENCE TO THE TREATMENT IN MODERN MEDICINE: POSSIBILITIES OF SOLUTION, IMPACT ON THE EFFECTIVENESS OF THERAPY AND DISEASE OUTCOMES. Rational Pharmacotherapy in Cardiology. 2017;13(4):519-524. (In Russ.) https://doi.org/10.20996/1819-6446-2017-13-4-519-524
Views: 709
Email this article 